Quality of clinical practice guidelines about red blood cell transfusion.


Journal

Journal of evidence-based medicine
ISSN: 1756-5391
Titre abrégé: J Evid Based Med
Pays: England
ID NLM: 101497477

Informations de publication

Date de publication:
May 2019
Historique:
received: 09 02 2018
accepted: 24 09 2018
pubmed: 5 12 2018
medline: 24 12 2019
entrez: 5 12 2018
Statut: ppublish

Résumé

Red blood cell (RBC) transfusions are essential in health care. The quality of recommendations included in clinical practice guidelines (CPG), regarding this intervention, has not been systematically evaluated. This paper systematically assessed CPGs for RBC-transfusion, to appraise their methodological quality, to explore changes in quality over time, and to assess the consistency of the hemoglobin threshold (HT) recommendations. We searched for CPGs that included recommendations of RBC-transfusion in generic databases, compiler entities, registries, clearinghouses and guideline developers. Three reviewers extracted data on CPGs characteristics and HT recommendations, independently appraised the quality of the studies using AGREE II and resolved disagreements by consensus. We examined 16 CPGs. Mean scores (mean ± SD) were: scope and purpose (59.4% ± 19.8%), stakeholder involvement (43.2% ± 22.6%), rigor of development (50% ± 25%), clarity of presentation (74.4% ± 12.6%), applicability (19.4% ± 18.8%), and editorial independence (41% ± 30%). Seven CPGs recommended a restrictive strategy for RBC transfusion; four CPGs gave a guarded statement considering an HT of 7 g/dL, as safe to prescribe an RBC transfusion. Eight CPGs did not provide an HT stating that RBC transfusions should not be prescribed by HT alone. Only 3 out of the 16 evaluated CPGs were "recommended" by the independent evaluators. Four domains "stakeholder involvement," "rigor of development," applicability," and "editorial independence" had serious shortcomings. Recommendations about the use of an HT for RBC-transfusion were heterogeneous among guidelines. Greater efforts are needed to provide high-quality CPGs in the RBC-transfusion practice.

Sections du résumé

BACKGROUND BACKGROUND
Red blood cell (RBC) transfusions are essential in health care. The quality of recommendations included in clinical practice guidelines (CPG), regarding this intervention, has not been systematically evaluated. This paper systematically assessed CPGs for RBC-transfusion, to appraise their methodological quality, to explore changes in quality over time, and to assess the consistency of the hemoglobin threshold (HT) recommendations.
METHODS METHODS
We searched for CPGs that included recommendations of RBC-transfusion in generic databases, compiler entities, registries, clearinghouses and guideline developers. Three reviewers extracted data on CPGs characteristics and HT recommendations, independently appraised the quality of the studies using AGREE II and resolved disagreements by consensus.
RESULTS RESULTS
We examined 16 CPGs. Mean scores (mean ± SD) were: scope and purpose (59.4% ± 19.8%), stakeholder involvement (43.2% ± 22.6%), rigor of development (50% ± 25%), clarity of presentation (74.4% ± 12.6%), applicability (19.4% ± 18.8%), and editorial independence (41% ± 30%). Seven CPGs recommended a restrictive strategy for RBC transfusion; four CPGs gave a guarded statement considering an HT of 7 g/dL, as safe to prescribe an RBC transfusion. Eight CPGs did not provide an HT stating that RBC transfusions should not be prescribed by HT alone.
CONCLUSIONS CONCLUSIONS
Only 3 out of the 16 evaluated CPGs were "recommended" by the independent evaluators. Four domains "stakeholder involvement," "rigor of development," applicability," and "editorial independence" had serious shortcomings. Recommendations about the use of an HT for RBC-transfusion were heterogeneous among guidelines. Greater efforts are needed to provide high-quality CPGs in the RBC-transfusion practice.

Identifiants

pubmed: 30511477
doi: 10.1111/jebm.12330
pmc: PMC6587995
doi:

Substances chimiques

Hemoglobins 0

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

113-124

Subventions

Organisme : Universidad UTE Facultad de Ciencias de la Salud Eugenio Espejo
Organisme : Carlos III Health Institute
ID : CPII15/0034

Informations de copyright

© 2018 The Authors. Journal of Evidence-Based Medicine published by Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.

Références

CMAJ. 2014 Feb 18;186(3):E123-42
pubmed: 24344144
Qual Saf Health Care. 2010 Dec;19(6):e50
pubmed: 21127093
CMAJ. 2010 Jul 13;182(10):E472-8
pubmed: 20513779
Ann Intern Med. 2013 Dec 3;159(11):770-779
pubmed: 24297193
Am J Med. 2014 Feb;127(2):124-131.e3
pubmed: 24331453
Br J Haematol. 2013 Feb;160(4):445-64
pubmed: 23278459
Arch Intern Med. 2012 Nov 26;172(21):1628-33
pubmed: 23089902
JAMA. 2014 Apr 2;311(13):1317-26
pubmed: 24691607
J Acquir Immune Defic Syndr. 2009 Dec;52 Suppl 2:S127-31
pubmed: 19901625
Qual Saf Health Care. 2003 Feb;12(1):18-23
pubmed: 12571340
Cochrane Database Syst Rev. 2012 Apr 18;(4):CD002042
pubmed: 22513904
Crit Care Med. 2014 Dec;42(12):2611-24
pubmed: 25167086
Chest. 2013 Aug;144(2):390-397
pubmed: 23450305
Cochrane Database Syst Rev. 2015 Dec 03;(12):CD009745
pubmed: 26633306
Implement Sci. 2008 Oct 13;3:43
pubmed: 18851739
CMAJ. 2010 Dec 14;182(18):E839-42
pubmed: 20603348
CMAJ. 2010 Jul 13;182(10):1045-52
pubmed: 20513780
Ann Thorac Surg. 2011 Mar;91(3):944-82
pubmed: 21353044
JAMA. 2016 Nov 15;316(19):2025-2035
pubmed: 27732721
Anesthesiology. 2015 Feb;122(2):241-75
pubmed: 25545654
Eur J Pediatr. 2009 Jul;168(7):789-99
pubmed: 18815809
Crit Care Med. 2009 Dec;37(12):3124-57
pubmed: 19773646
JAMA. 2002 Sep 25;288(12):1499-507
pubmed: 12243637
J Cardiopulm Rehabil Prev. 2015 Jan-Feb;35(1):1-12
pubmed: 25068394
Anesthesiology. 2006 Jul;105(1):198-208
pubmed: 16810012
Ann Intern Med. 2012 Apr 3;156(7):525-31
pubmed: 22473437
J Evid Based Med. 2019 May;12(2):113-124
pubmed: 30511477
Blood. 2001 Mar 1;97(5):1180-95
pubmed: 11222359
Qual Saf Health Care. 2010 Dec;19(6):e58
pubmed: 21127089
Farm Hosp. 2013 May-Jun;37(3):209-35
pubmed: 23789799
Cochrane Database Syst Rev. 2015 Jul 14;(7):CD009330
pubmed: 26171902
BMJ. 1999 Feb 20;318(7182):527-30
pubmed: 10024268

Auteurs

Daniel Simancas-Racines (D)

Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC), Centro Asociado Cochrane de Ecuador/Red Iberoamericana, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.

Nadia Montero-Oleas (N)

Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC), Centro Asociado Cochrane de Ecuador/Red Iberoamericana, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.

Robin W M Vernooij (RWM)

Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.

Ingrid Arevalo-Rodriguez (I)

Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC), Centro Asociado Cochrane de Ecuador/Red Iberoamericana, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.

Paulina Fuentes (P)

Iberoamerican Cochrane Centre, Barcelona, Spain, Faculty of Medicine and Dentistry, Universidad de Antofagasta, Antofagasta, Chile.

Ignasi Gich (I)

Iberomerican Cochrane Centre, Clinical Epidemiology and Public Health Department, Institute of Biomedical Research (IIB Sant Pau), CIBER de Epidemiología y Salud Pública (CIBERESP), Spain.

Ricardo Hidalgo (R)

Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC), Centro Asociado Cochrane de Ecuador/Red Iberoamericana, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.

Maria José Martinez-Zapata (MJ)

Iberomerican Cochrane Centre, Clinical Epidemiology and Public Health Department, Institute of Biomedical Research (IIB Sant Pau), CIBER de Epidemiología y Salud Pública (CIBERESP), Spain.
Iberoamerican Cochrane Centre, Institute of Biomedical Research (IIB Sant Pau), CIBER Epidemiología y Salud Pública (CIBERESP), Universitat Autònoma de Barcelona, Barcelona, Spain.

Xavier Bonfill (X)

Iberoamerican Cochrane Centre, Institute of Biomedical Research (IIB Sant Pau), CIBER Epidemiología y Salud Pública (CIBERESP), Universitat Autònoma de Barcelona, Barcelona, Spain.

Pablo Alonso-Coello (P)

Iberomerican Cochrane Centre, Clinical Epidemiology and Public Health Department, Institute of Biomedical Research (IIB Sant Pau), CIBER de Epidemiología y Salud Pública (CIBERESP), Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH